CHENGDU,
China, July 12, 2024 /PRNewswire/ -- Qilian
International Holding Group Limited (NASDAQ: QLI) ("Qilian" or the
"Company"), a China-based
pharmaceutical and chemical products manufacturer, today
announced that on July 10, 2024,
NASDAQ notified the Company that it has determined that for the 10
consecutive business days, from June 21,
2024 to July 9, 2024, the
closing bid price of the Company's Class A ordinary shares has been
at $1.00 per share or greater.
Accordingly, the Company has regained compliance with Listing Rule
5550(a)(2) and NASDAQ has closed this matter.
About Qilian International Holding Group Ltd
Qilian International Holding Group Ltd, headquartered in
Gansu, China, is a pharmaceutical
and chemical products manufacturer in China. It focuses on the development,
manufacture, marketing and sale of licorice products,
oxytetracycline products, traditional Chinese medicine derivatives
product, heparin product, sausage casings, and fertilizers. The
Company's products are sold in more than 20 provinces in
China. For more information, visit
the Company's website at https://www.qilianholding.com/.
Safe Harbor Statement
Certain statements made in this release are "forward looking
statements" within the meaning of the "safe harbor" provisions of
the United States Private Securities Litigation Reform Act of 1995.
When used in this press release, the words "estimates,"
"projected," "expects," "anticipates," "forecasts," "plans,"
"intends," "believes," "seeks," "may," "will," "should," "future,"
"propose" and variations of these words or similar expressions (or
the negative versions of such words or expressions) are intended to
identify forward-looking statements. These forward-looking
statements are not guarantees of future performance, conditions or
results, and involve a number of known and unknown risks,
uncertainties, assumptions and other important factors, many of
which are outside the Company's control, that could cause actual
results or outcomes to differ materially from those discussed in
the forward-looking statements. Important factors, among others,
are: the ability to manage growth; ability to identify and
integrate other future acquisitions; ability to obtain additional
financing in the future to fund capital expenditures; fluctuations
in general economic and business conditions; costs or other factors
adversely affecting our profitability; litigation involving
patents, intellectual property, and other matters; potential
changes in the legislative and regulatory environment; a pandemic
or epidemic. The forward-looking statements contained in this
release are also subject to other risks and uncertainties,
including those more fully described in the Company's filings with
the Securities and Exchange Commission, which are available for
review at www.sec.gov. The Company undertakes no obligation to
update or revise any forward-looking statements, whether as a
result of new information, future events or otherwise, except as
required by applicable law. Such information speaks only as of the
date of this release.
View original
content:https://www.prnewswire.com/news-releases/qilian-international-holding-group-ltd-regained-compliance-with-nasdaqs-minimum-bid-price-rule-302195671.html
SOURCE Qilian International Holding Group Limited